Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement

Overview of attention for article published in Blood Cancer Journal, December 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 77 X users
patent: 1 patent

wikipedia: 1 Wikipedia page
guideline: 1 clinical guideline source

Readers on

mendeley: 99 Mendeley

So far, Altmetric has seen 99 X posts from 77 X users, with an upper bound of 377,836 followers.

RT @VincentRK: Using clinical grade mass spectrometry, we estimate 5% of the general population age 50 and older has a monoclonal protein,…

Using clinical grade mass spectrometry, we estimate 5% of the general population age 50 and older has a monoclonal protein, (MGUS). Our prior estimate with electrophoresis and immunofixation was 3%. @BloodCancerJnl @MayoMyeloma https://t.co/CFfy5MHkXT

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 95 additional X posts.